Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MEDP	$591.29	-0.35%	146.43K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MEDP	$591.29	-0.4%	146.43K
3
4
5
6

MEDP

Get Medpace Holdings, Inc. Data in Excel

Get Medpace Holdings, Inc. Data in Excel